Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

25.90 +0.50 (+1.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Moderna, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in United Arab Emirates
From Moderna, Inc.
Via Business Wire
Dr. Paul Burton to Join Moderna as Chief Medical Officer
From Moderna, Inc.
Via Business Wire
Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
From Moderna, Inc.
Via Business Wire
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
From Moderna, Inc.
Via Business Wire
Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States
From Moderna, Inc.
Via Business Wire
Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel
From Moderna, Inc.
Via Business Wire
Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents
From Moderna, Inc.
Via Business Wire
Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union
From Moderna, Inc.
Via Business Wire
Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Why The Relaxation In Lockdowns Is Expected To Drive The Demand For COVID-19 Diagnostics Market
Via FinancialNewsMedia
Exposures COVID-19
UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility
From Moderna, Inc.
Via Business Wire
Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands
From Moderna, Inc.
Via Business Wire
Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna to Present at Upcoming Investor Conferences in June 2021
From Moderna, Inc.
Via Business Wire
Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Fourth Annual Science Day
From Moderna, Inc.
Via Business Wire
Moderna Announces TeenCOVE Study of its COVID-19 Vaccine in Adolescents Meets Primary Endpoint and Plans to Submit Data to Regulators in Early June
From Moderna, Inc.
Via Business Wire
Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline
From Moderna, Inc.
Via Business Wire
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna and South Korea Explore Collaboration on mRNA Vaccines
From Moderna, Inc.
Via Business Wire
Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna to Host Fourth Annual Science Day on May 27, 2021
From Moderna, Inc.
Via Business Wire
Moderna to Establish an International Business Services Hub in Warsaw, Poland
From Moderna, Inc.
Via Business Wire
Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna to Present at the Bank of America 2021 Healthcare Conference
From Moderna, Inc.
Via Business Wire
Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
From Moderna, Inc.
Via Business Wire
Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses
From Moderna, Inc.
Via Business Wire
Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern
From Moderna, Inc.
Via Business Wire
Moderna Announces Expansion of its Manufacturing Technology Center in Massachusetts
From Moderna, Inc.
Via Business Wire
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.